Valproate add-on therapy for drug-resistant focal epilepsy

Gianatsi, Myrsini ORCID: 0000-0003-3664-4302, Bresnahan, Rebecca, Hill, Ruaraidh A ORCID: 0000-0002-2801-0505, Nevitt, Sarah J, Marson, Anthony G ORCID: 0000-0002-6861-8806 and Tudur Smith, Catrin ORCID: 0000-0003-3051-1445 (2021) Valproate add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews, 2021 (7). ISSN 1465-1858, 1465-1858

[thumbnail of Gianatsi_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf]

Text
Gianatsi_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf - Author Accepted Manuscript
Download (117kB) | Preview

Official URL: https://doi.org/10.1002/14651858.cd014701

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and tolerability of valproate when used as add-on therapy for people with drug-resistant focal epilepsy.

Item Type:	Article
Uncontrolled Keywords:	32 Biomedical and Clinical Sciences, 42 Health Sciences
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	23 Aug 2021 08:32
Last Modified:	06 Dec 2024 20:03
DOI:	10.1002/14651858.cd014701
Related URLs:	Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3134025